Johnson James R, Owens Krista, Manges Amee R, Riley Lee W
Infectious Diseases (111F), Minneapolis VA Medical Center, One Veterans Dr., Minneapolis, MN 55417, USA.
J Clin Microbiol. 2004 Jun;42(6):2618-22. doi: 10.1128/JCM.42.6.2618-2622.2004.
PCR primers specific for the recently described antimicrobial resistance-associated Escherichia coli clonal group A (CGA), a widespread cause of drug-resistant urinary tract infections in the United States, were devised on the basis of a novel single-nucleotide polymorphism identified within the housekeeping gene fumC, i.e., C288T. In comparison with two reference PCR-based fingerprinting methods, ERIC2 PCR and random amplified polymorphic DNA (RAPD) analysis, a PCR assay incorporating the new primers provided 100% sensitivity and 100% specificity for the detection of CGA among 138 diverse clinical and reference E. coli isolates. E. coli reference (ECOR) strain 47 was shown to be a member or a close relative of CGA (by ERIC2 PCR and RAPD analysis, respectively) and yielded a positive assay result. The new CGA-specific PCR assay, which exhibited interlaboratory reproducibility and stability under various experimental conditions, should allow the rapid and specific detection of CGA by any laboratory equipped for diagnostic PCR.
针对最近描述的与抗菌药物耐药性相关的大肠杆菌克隆群A(CGA)设计了PCR引物,该克隆群是美国耐药性尿路感染的常见病因,其设计依据是在内参基因fumC中鉴定出的一个新的单核苷酸多态性,即C288T。与两种基于PCR的参考指纹图谱方法(ERIC2 PCR和随机扩增多态性DNA(RAPD)分析)相比,采用新引物的PCR检测法在检测138株不同的临床和参考大肠杆菌分离株中的CGA时,灵敏度和特异性均达到100%。大肠杆菌参考(ECOR)菌株47被证明是CGA的一个成员或近亲(分别通过ERIC2 PCR和RAPD分析),检测结果呈阳性。这种新的CGA特异性PCR检测法在各种实验条件下均表现出实验室间的可重复性和稳定性,任何具备诊断PCR设备的实验室都应能快速、特异性地检测CGA。